The safety and efficacy of elective percutaneous coronary intervention using bivalirudin versus heparin and glycoprotein IIb/IIIa inhibitors: Insight from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium

被引：0
|
作者：
Gurm, H [1 ]
Smith, DE [1 ]
Khanal, S [1 ]
Riba, A [1 ]
Carter, AJ [1 ]
LaLonde, T [1 ]
Kline-Rogers, EM [1 ]
Moscucci, M [1 ]
机构：
[1] Univ Michigan, Med Ctr, Ann Arbor, MI USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2006年 / 47卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：45B / 46B
页数：2
相关论文
共 50 条
  • [31] Not So Harmless: Marijuana Use and In-hospital Outcomes After Percutaneous Coronary Intervention: Insights From the Blue Cross Blue Shield of Michigan Cardiovascular Consortium
    Yoo, Sang Gune K.
    Seth, Milan
    Earl, Thomas
    Ruwende, Cyril
    Karve, Milind
    Shah, Ibrahim
    Hill, Thomas
    Gurm, Hitinder S.
    Sukul, Devraj
    CIRCULATION, 2020, 142
  • [32] Hospital and Operator Variation in Cardiac Rehabilitation Referral and Participation After Percutaneous Coronary Intervention: Insights From Blue Cross Blue Shield of Michigan Cardiovascular Consortium
    Sukul, Devraj
    Seth, Milan
    Thompson, Michael P.
    Keteyian, Steven J.
    Boyden, Thomas F.
    Syrjamaki, John D.
    Yaser, Jessica
    Likosky, Donald S.
    Gurm, Hitinder S.
    CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2021, 14 (11): : E008242
  • [33] Gender differences in adverse outcomes after contemporary percutaneous coronary intervention: An analysis from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2) percutaneous coronary intervention registry
    Duvernoy, Claire S.
    Smith, Dean E.
    Manohar, Prerana
    Schaefer, Ann
    Kline-Rogers, Eva
    Share, David
    McNamara, Richard
    Gurm, Hitinder S.
    Moscucci, Mauro
    AMERICAN HEART JOURNAL, 2010, 159 (04) : 677 - U210
  • [34] Comparative Safety and Effectiveness of Orbital and Rotational Atherectomy in Patients Undergoing Percutaneous Coronary Intervention: Insights From the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2)
    Aggarwal, Devika
    Seth, Milan
    Perdoncin, Emily
    Schreiber, Theodore
    Kaki, Amir
    Alaswad, Khaldoon
    Menees, Daniel
    Sukul, Devraj
    Gurm, Hitinder
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 74 (13) : B25 - B25
  • [35] Efficacy and Safety of Bivalirudin and Heparin With or Without Glycoprotein IIb/IIIa Inhibitors in Patients Who Underwent Percutaneous Coronary Intervention: A Systematic Review and Network Meta-Analysis
    Adnan, Maryam
    Bakhtiari, Muhammad Irtaza
    Hamza, Mohammad
    Alraies, Chadi
    Naveed, Hamza
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 84 (18) : B34 - B34
  • [36] Safety and efficacy of glycoprotein IIb/IIIa inhibitors with intravenous enoxaparin in patients undergoing elective percutaneous coronary intervention: Findings from the STEEPLE trial
    Steinhubl, S
    White, H
    King, S
    Gallo, R
    Montalescot, G
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (04) : 45B - 45B
  • [37] Persistent Racial Disparities in Risks of Readmission and Mortality After Percutaneous Coronary Intervention in the Contemporary Era: Insights From the Blue Cross Blue Shield of Michigan Cardiovascular Consortium
    Spehar, Stephanie
    Seth, Milan
    Alaswad, Khaldoon
    Schreiber, Theodore
    Berman, Aaron
    Syrjamaki, John
    Ali, Omar
    Bader, Yousef
    Gurm, Hitinder S.
    Sukul, Devraj
    CIRCULATION, 2020, 142
  • [38] THE COMPARATIVE EFFICACY OF BIVALIRUDIN IS MARKEDLY ATTENUATED BY USE OF RADIAL ACCESS: INSIGHTS FROM BLUE CROSS BLUE SHIELD OF MICHIGAN CARDIOVASCULAR CONSORTIUM (BMC2)
    Perdoncin, Emily
    Seth, Milan
    Gurm, Hitinder
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 65 (10) : A19 - A19
  • [39] Real-World Safety and Efficacy of Glycoprotein IIb/IIIa Inhibitors during Percutaneous Coronary Intervention
    Casterella, Peter J.
    Revenaugh, James R.
    Burke, James L.
    Pearson, Robert R.
    Bair, Tami L.
    May, Heidi T.
    Horne, Benjamin
    Anderson, Jeffrey L.
    Muhlestein, Joseph B.
    JOURNAL OF INVASIVE CARDIOLOGY, 2008, 20 (03): : 94 - 98
  • [40] Economic evaluation of bivalirudin with provisional glycoprotein IIb/IIIa inhibition versus heparin with routine glycoprotein IIb/IIIa inhibition for percutaneous coronary intervention - Results from the REPLACE-2 trial
    Cohen, DJ
    Lincoff, AM
    Lavelle, TA
    Chen, HL
    Bakhai, A
    Berezin, RH
    Jackman, D
    Sarembock, IJ
    Topol, EJ
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 44 (09) : 1792 - 1800
12345